Rivaroxaban May Lead to Higher GI Bleeding Risk Than Other DOACs
Rivaroxaban was associated with an increased risk of overall and major gastrointestinal bleeding, compared with apixaban or dabigatran, a study shows.
Source: medscape.com
Stay updated with breaking news from Upper Gi Bleeding. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Rivaroxaban was associated with an increased risk of overall and major gastrointestinal bleeding, compared with apixaban or dabigatran, a study shows.